Pediatrix Medical
297 hedge funds and large institutions have $2.18B invested in Pediatrix Medical in 2019 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 115 increasing their positions, 98 reducing their positions, and 53 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 115 | Existing positions reduced: 98
2.05% less ownership
Funds ownership: 93.42% → 91.37% (-2.1%)
3% less funds holding
Funds holding: 307 → 297 (-10)
15% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 53
20% less capital invested
Capital invested by funds: $2.74B → $2.18B (-$558M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
88% less call options, than puts
Call options by funds: $223K | Put options by funds: $1.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$40.8M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$35.2M |
| 3 |
Lazard Asset Management
New York
|
+$28M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
+$23.7M |
| 5 |
PP
Prudential plc
London, England,
United Kingdom
|
+$15.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BHG
Blue Harbour Group
Greenwich,
Connecticut
|
-$108M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$64.1M |
| 3 |
EARNEST Partners
Atlanta,
Georgia
|
-$59.9M |
| 4 |
EM
Elliott Management
New York
|
-$56M |
| 5 |
Pzena Investment Management
New York
|
-$35.5M |
MD Hedge Fund Activity: Q1 2019 in Review
297 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q1 2019, worth a combined $2.18B — down 20% from $2.74B a quarter earlier.
Sellers outnumbered buyers: 53 funds closed out of MD and 45 opened new positions — a net loss of 8 holders — while 98 trimmed existing stakes and 115 added.
The largest buyer was D.E. Shaw & Co, adding an estimated $40.8M. The largest seller was Blue Harbour Group, cutting an estimated $108M.
- 297 institutional investors held Pediatrix Medical (MD) as of Q1 2019, down from 307 in Q4 2018.
- Funds reported $2.18B of Pediatrix Medical stock for Q1 2019, down 20% quarter-over-quarter.
- 45 funds opened new Pediatrix Medical positions in Q1 2019 and 53 closed out, a net change of -8 holders.
- The largest Pediatrix Medical buyer in Q1 2019 was D.E. Shaw & Co, an estimated $40.8M added.
- The largest Pediatrix Medical seller in Q1 2019 was Blue Harbour Group, an estimated $108M sold.
Based on aggregated 13F filings for Q1 2019.